This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
- Status
- RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Non-small Cell Lung Cancer
Related studies linked through entity extraction aliases.
68Ga-grazytracer PET/CT for Early Assessment of Response to Neoadjuvant Immunotherapy in Resectable NSCLC
- Status
- RECRUITING
- Phase
- N/A
Neoadjuvant Befotertinib Combined Bevacizumab or Platinum-based Double Chemotherapy for Resectable Locally-advanced EGFR Mutation-positive Non-Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Prospective Trial Assessing Real World Outcomes Response to Pembro in Black Patients w/ NSCLC
- Status
- RECRUITING
- Phase
- PHASE2
Phase I/II Study of Neoadjuvant Cemiplimab and Dupilumab in Early-Stage Non-Small Cell Lung Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Surgery After Verifying Existing Disease in Locally Advanced Operable Lung Cancer: A Pilot Study
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
PRedictive Value of Multiparametric Dynamic WB 18F-FDG-PET Imaging on a LAFOV System for FIRST-line Chemo-immunotherapy Efficacy in Advanced Non-small-cell Lung Cancer: PROFIL-1
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Multicenter Analysis of Different Approaches in Segmentectomies in Early-stage Lung Cancer
- Status
- RECRUITING
- Phase
- N/A
Neoadjuvant Envafolimab Plus Disitamab Vedotin and Carboplatin in Resectable HER2-Mutant Non-Small-Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Pembrolizumab With or Without Chemotherapy in Combination With Additional Treatments for Advanced Non-Small Cell Lung Cancer (NSCLC) (MK-3475-01G/KEYMAKER U01)
- Status
- RECRUITING
- Phase
- PHASE2
Reduced CT + Anti-PD-1 as First Line Tx in Vulnerable Older Adults w/Adv <50% PD-L1 Non-Small Cell Lung Cancer (NSCLC)
- Status
- RECRUITING
- Phase
- PHASE2
A Real-world Study on the Treatment of Non-small Cell Lung Cancer With Leptomeningeal Metastasis in China
- Status
- RECRUITING
- Phase
- N/A
Chemotherapy Plus Immunotherapy Combined With SBRT as Neoadjuvant Therapy for Patients With Resectable NSCLC
- Status
- RECRUITING
- Phase
- PHASE2
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
A Study of SKB264 in Combination With Pembrolizumab Versus Chemotherapy in Combination With Pembrolizumab as First-Line Treatment for PD-L1 Negative Patients With Locally Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Minimal Residual Disease Guiding Adjuvant Therapy in Stage I NSCLC
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Study of BEBT-109 in Subjects With EGFR Exon 20 Insertion Mutations Non-Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Multi-omics Study of Early-stage Lung Cancer With Distinct Phenotypes
- Status
- RECRUITING
- Phase
- N/A
A Clinical Study of Pembrolizumab (+) Berahyaluronidase Alfa (MK-3475A) to Treat Newly-diagnosed Metastatic Non-small Cell Lung Cancer (MK-3475A-F84)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
- Status
- RECRUITING
- Phase
- PHASE2